Cargando…
The role of a two-assay serological testing strategy for anti-HCV screening in low-prevalence populations
HCV screening depends mainly on a one-assay anti-HCV testing strategy that is subject to an increased false-positive rate in low-prevalence populations. In this study, a two-assay anti-HCV testing strategy was applied to screen HCV infection in two groups, labelled group one (76,442 people) and grou...
Autores principales: | Huang, Yanfang, Pan, Huifen, Gao, Qin, Lv, Panpan, Xu, Xiaoqin, Zhao, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062551/ https://www.ncbi.nlm.nih.gov/pubmed/33888806 http://dx.doi.org/10.1038/s41598-021-88138-2 |
Ejemplares similares
-
One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling
por: Parry, John V., et al.
Publicado: (2017) -
Droplet digital PCR (ddPCR) for the detection and quantification of Ureaplasma spp.
por: Huang, Yanfang, et al.
Publicado: (2021) -
Prevalence of active HCV infection among the blood donors of Khyber Pakhtunkwa and FATA region of Pakistan and evaluation of the screening tests for anti-HCV
por: Khan, Najib U, et al.
Publicado: (2011) -
Can HCV Core Ag Testing Replace the Routine Screening Assays in Patients on Hemodialysis?
por: Einollahi, Behzad, et al.
Publicado: (2014) -
Evaluating the utility of a two‐assay serological algorithm for hepatitis C screening in a low prevalence population
por: Rogers, Kai J., et al.
Publicado: (2023)